Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Thoracic 1

Conditions

Advanced Solid Tumors 2Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × TAS-114 × Clear all
NCT02855125 2024-09-19

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Taiho Oncology, Inc.

Phase 2 Completed
128 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02454062 2024-09-04

A Trial of TAS-114 in Combination With S-1

Taiho Oncology, Inc.

Phase 1 Completed
120 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01610479 2017-08-04

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Taiho Pharmaceutical Co., Ltd.

Phase 1 Completed
120 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡